Related references
Note: Only part of the references are listed.AAV-mediated Gene Therapy Halts Retinal Degeneration in PDE6β-deficient Dogs
Virginie Pichard et al.
MOLECULAR THERAPY (2016)
Structural and molecular bases of rod photoreceptor morphogenesis and disease
Theodore G. Wensel et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2016)
Retinitis pigmentosa: impact of different Pde6a point mutations on the disease phenotype
Vithiyanjali Sothilingam et al.
HUMAN MOLECULAR GENETICS (2015)
Halting progressive neurodegeneration in advanced retinitis pigmentosa
Susanne F. Koch et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Long-Term Effect of Gene Therapy on Leber's Congenital Amaurosis
J. W. B. Bainbridge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A short N-terminal domain of HDAC4 preserves photoreceptors and restores visual function in retinitis pigmentosa
Xinzheng Guo et al.
NATURE COMMUNICATIONS (2015)
Gene therapy restores vision in rd1 mice after removal of a confounding mutation in Gpr179
Koji M. Nishiguchi et al.
NATURE COMMUNICATIONS (2015)
Viral-mediated vision rescue of a novel AIPL1 cone-rod dystrophy model
Cristy A. Ku et al.
HUMAN MOLECULAR GENETICS (2015)
Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach
F. M. Mowat et al.
GENE THERAPY (2014)
Mid-stage intervention achieves similar efficacy as conventional early-stage treatment using gene therapy in a pre-clinical model of retinitis pigmentosa
Katherine J. Wert et al.
HUMAN MOLECULAR GENETICS (2014)
RPE65 gene therapy slows cone loss in Rpe65-deficient dogs
F. M. Mowat et al.
GENE THERAPY (2013)
Gene therapy provides long-term visual function in a pre-clinical model of retinitis pigmentosa
Katherine J. Wert et al.
HUMAN MOLECULAR GENETICS (2013)
Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years
Samuel G. Jacobson et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Restoration of Vision in the pde6β-deficient Dog, a Large Animal Model of Rod-cone Dystrophy
Lolita Petit et al.
MOLECULAR THERAPY (2012)
Lentivirus-mediated expression of cDNA and shRNA slows degeneration in retinitis pigmentosa
Joaquin Tosi et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Gene therapy in the second eye of RPE65-deficient dogs improves retinal function
M. J. Annear et al.
GENE THERAPY (2011)
Long-term Retinal Function and Structure Rescue Using Capsid Mutant AAV8 Vector in the rd10 Mouse, a Model of Recessive Retinitis Pigmentosa
Ji-jing Pang et al.
MOLECULAR THERAPY (2011)
Novel Properties of Tyrosine-mutant AAV2 Vectors in the Mouse Retina
Hilda Petrs-Silva et al.
MOLECULAR THERAPY (2011)
Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutations
X. Sun et al.
GENE THERAPY (2010)
rAAV2/5 gene-targeting to rods: dose-dependent efficiency and complications associated with different promoters
W. A. Beltran et al.
GENE THERAPY (2010)
Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration
Francesca Simonelli et al.
MOLECULAR THERAPY (2010)
Human RPE65 Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 Year
Artur V. Cideciyan et al.
HUMAN GENE THERAPY (2009)
New mouse models for recessive retinitis pigmentosa caused by mutations in the Pde6a gene
Kenji Sakamoto et al.
HUMAN MOLECULAR GENETICS (2009)
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
Albert M. Maguire et al.
LANCET (2009)
Vision 1 Year after Gene Therapy for Leber's Congenital Amaurosis
Artur V. Cideciyan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Characterization of a Canine Model of Autosomal Recessive Retinitis Pigmentosa due to a PDE6A Mutation
Nalinee Tuntivanich et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
William W. Hauswirth et al.
HUMAN GENE THERAPY (2008)
Functional and structural modifications during retinal degeneration in the rd10 mouse
R. Barhoum et al.
NEUROSCIENCE (2008)
Safety and efficacy of gene transfer for Leber's congenital amaurosis
Albert M. Maguire et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of gene therapy on visual function in Leber's congenital amaurosis
James W. B. Bainbridge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses
Li Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics
Artur V. Cideciyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
AAV-mediated gene therapy for retinal degeneration in the rd10 mouse containing a recessive PDEβ mutation
Ji-jing Pang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
A novel method for objective vision testing in canine models of inherited retinal disease
Patricia M. Gearhart et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Retinal organization in the retinal degeneration 10 (rd10) mutant mouse: A morphological and ERG study
Claudia Gargini et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2007)
Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection
Samuel G. Jacobson et al.
MOLECULAR THERAPY (2006)
Genotype-phenotype correlation of mouse Pde6b mutations
AW Hart et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Identification of gene expression changes associated with the progression of retinal degeneration in the rd1 mouse
AS Hackam et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina
JWB Bainbridge et al.
GENE THERAPY (2003)
Muller cell and neuronal remodeling in retinal detachment and reattachment and their potential consequences for visual recovery: a review and reconsideration of recent data
SK Fisher et al.
VISION RESEARCH (2003)
Gene expression networks underlying retinoic acid-induced differentiation of human retinoblastoma cells
AM Li et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors
S Zolotukhin et al.
METHODS (2002)
Modifications of retinal neurons in a mouse model of retinitis pigmentosa
E Strettoi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
